|
1
|
Salih AM, Pshtiwan LR, Abdullah AM,
Qaradakhy AJ, Kakamad FH, Ali HO, Salih KM, Rahim HM, Abdalla BA,
Hassan MN and Mohammed SH: Carcinoma arising from fibroadenoma;
presentation and management; a case series. Barw Med J. 1:1–28.
2023.
|
|
2
|
Bacon DR, Ngeve SM and Jordan SG:
Granulomatous mastitis: An underdiagnosed inflammatory disease
afflicting minority women. Radiol Case Rep. 16:3990–3994.
2021.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Martinez-Ramos D, Simon-Monterde L,
Suelves-Piqueres C, Queralt-Martin R, Granel-Villach L,
Laguna-Sastre JM, Nicolau MJ and Escrig-Sos J: Idiopathic
granulomatous mastitis: A systematic review of 3060 patients.
Breast J. 25:1245–1250. 2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Esmaeil NK, Salih AM, Hammood ZD, Pshtiwan
LR, Abdullah AM, Kakamad FH, Abdullah HO, Ahmed GS, Abdalla BA and
Salih RQ: Clinical, microbiological, immunological and hormonal
profiles of patients with granulomatous mastitis. Biomed Rep.
18(41)2023.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Esmaeil NK, Salih AM, Pshtiwan LR,
Muhialdeen AS, Abdullah AM, Hama JI, Hammood ZD, Kakamad FH, Tahir
SH, Abdalla BA, et al: Management of idiopathic granulomatous
mastitis: A single institution experience. Breast Care (Basel).
18:231–238. 2023.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Mahmood ZH, Mohemed FM, Fatih BN, Qadir AA
and Abdalla SH: Cancer publications in one year (2022); a
cross-sectional study. Barw Med J. 1:2023.
|
|
7
|
Van Seijen M, Lips EH, Thompson AM,
Nik-Zainal S, Futreal A, Hwang ES, Verschuur E, Lane J, Jonkers J,
Rea DW, et al: Ductal carcinoma in situ: To treat or not to treat,
that is the question. Br J Cancer. 121:285–292. 2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Allred DC: Ductal carcinoma in situ:
Terminology, classification, and natural history. J Natl Cancer
Inst Monogr. 2010:134–138. 2010.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Ward EM, DeSantis CE, Lin CC, Kramer JL,
Jemal A, Kohler B, Brawley OW and Gansler T: Cancer statistics:
Breast cancer in situ. CA Cancer J Clin. 65:481–495.
2015.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Ryser MD, Hendrix LH, Worni M, Liu Y,
Hyslop T and Hwang ES: Incidence of ductal carcinoma in situ in the
United States, 2000-2014. Cancer Epidemiol Biomarkers Prev.
28:1316–1323. 2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Özşen M, Tolunay Ş and Gökgöz MŞ: Case
report: Ductal carcinoma in situ within a granulomatous mastitis.
Eur J Breast Health. 14:186–188. 2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Oddó D, Domínguez F, Gómez N, Méndez GP
and Navarro ME: Granulomatous lobular mastitis associated with
ductal carcinoma in situ of the breast. SAGE Open Med Case Rep.
7(2050313X19836583)2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Tavakol M, Alvand S, Azmoudeh Ardalan F
and Assarian A: Idiopathic granulomatous mastitis with incidental
lobular carcinoma in situ: A case report. Arch Breast Cancer.
9:315–319. 2022.
|
|
14
|
Rami-Porta R, Bolejack V and Goldstraw P:
The new tumor, node, and metastasis staging system. Semin Respir
Crit Care Med. 32:44–51. 2011.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Balleyguier C, Ayadi S, Van Nguyen K,
Vanel D, Dromain C and Sigal R: BIRADS classification in
mammography. Eur J Radiol. 61:192–194. 2007.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Hammond ME, Hayes DF, Dowsett M, Allred
DC, Hagerty KL, Badve S, Fitzgibbons PL, Francis G, Goldstein NS,
Hayes M, et al: American society of clinical oncology/college of
American pathologists guideline recommendations for
immunohistochemical testing of estrogen and progesterone receptors
in breast cancer (unabridged version). Arch Pathol Lab Med.
134:e48–e72. 2010.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Benson JR and Dumitru D: Idiopathic
granulomatous mastitis: Presentation, investigation and management.
Future Oncol. 12:1381–1394. 2016.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Kessler E and Wolloch Y: Granulomatous
mastitis: A lesion clinically simulating carcinoma. Am J Clin
Pathol. 58:642–646. 1972.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Scott DM: Inflammatory diseases of the
breast. Best Pract Res Clin Obstet Gynaecol. 83:72–87.
2022.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Wolfrum A, Kümmel S, Theuerkauf I, Pelz E
and Reinisch M: Granulomatous mastitis: A therapeutic and
diagnostic challenge. Breast Care (Basel). 13:413–418.
2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Kerlikowske K: Epidemiology of ductal
carcinoma in situ. J Natl Cancer Inst Monogr. 2010:139–141.
2010.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Sakurai T, Oura S, Tanino H, Yoshimasu T,
Kokawa Y, Kinoshita T and Okamura Y: A case of granulomatous
mastitis mimicking breast carcinoma. Breast Cancer. 9:265–268.
2002.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Yin Y, Liu X, Meng Q, Han X, Zhang H and
Lv Y: Idiopathic granulomatous mastitis: Etiology, clinical
manifestation, diagnosis and treatment. J Invest Surg. 35:709–720.
2022.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Virnig BA, Wang SY, Shamilyan T, Kane RL
and Tuttle TM: Ductal carcinoma in situ: Risk factors and impact of
screening. J Natl Cancer Inst Monogr. 2010:113–116. 2010.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Trentham-Dietz A, Newcomb PA, Storer BE
and Remington PL: Risk factors for carcinoma in situ of the breast.
Cancer Epidemiol Biomarkers Prev. 9:697–703. 2000.PubMed/NCBI
|
|
26
|
Wohlfahrt J, Rank F, Kroman N and Melbye
M: A comparison of reproductive risk factors for CIS lesions and
invasive breast cancer. Int J Cancer. 108:750–753. 2004.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Moore MM, Chua W, Charles KA and Clarke
SJ: Inflammation and cancer: Causes and consequences. Clin
Pharmacol Ther. 87:504–508. 2010.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Morrison L, Laukkanen JA, Ronkainen K,
Kurl S, Kauhanen J and Toriola AT: Inflammatory biomarker score and
cancer: A population-based prospective cohort study. BMC Cancer.
16(80)2016.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Lambe M, Johansson ALV, Altman D and
Eloranta S: Mastitis and the risk of breast cancer. Epidemiology.
20:747–751. 2009.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Chen YC, Chan CH, Lim YB, Yang SF, Yeh LT,
Wang YH, Chou MC and Yeh CB: Risk of breast cancer in women with
mastitis: A retrospective population-based cohort study. Medicina
(Kaunas). 56(372)2020.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Destek S, Gul VO and Ahioglu S: A variety
of gene polymorphisms associated with idiopathic granulomatous
mastitis. J Surg Case Rep. 2016(rjw156)2016.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Zhu Q, Wang L and Wang P: The
identification of gene expression profiles associated with
granulomatous mastitis. Breast Care (Basel). 16:319–327.
2021.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Kaviani A, Zand S, Karbaksh M and Ardalan
FA: Synchronous idiopathic granulomatosis mastitis and breast
cancer: A case report and review of literature. Arch Breast Cancer.
4:32–36. 2017.
|
|
34
|
Kiyak G, Dumlu EG, Kilinc I, Tokaç M,
Akbaba S, Gurer A, Ozkardes AB and Kilic M: Management of
idiopathic granulomatous mastitis: Dilemmas in diagnosis and
treatment. BMC Surg. 14(66)2014.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Cappelli LC and Shah AA: The relationships
between cancer and autoimmune rheumatic diseases. Best Pract Res
Clin Rheumatol. 34(101472)2020.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Mitchell KB and Kuerer H: Ductal carcinoma
in situ: Treatment update and current trends. Curr Oncol Rep.
17(48)2015.PubMed/NCBI View Article : Google Scholar
|
